SCHEMBL23117246

SCHEMBL23117246

CCOC(=O)Cc1coc2c(F)cccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.46
PSMB5 P28074 2/20 0.45
PSMB8 P28062 1/20 0.45
NLRP3 Q96P20 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 2/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
MAOB P27338 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29322303 0.84 PKM (0.46) PKML3MBTL1SMN1; SMN2ALDH1A1TP53
SCHEMBL23115218 0.84 PKM (0.46) PKML3MBTL1SMN1; SMN2ALDH1A1TP53
SCHEMBL6839194 0.83 PSMB5 (0.49) PKMPSMB5PSMB8L3MBTL1SMN1; SMN2
SCHEMBL18331032 0.81 PSMB5 (0.49) PSMB5PSMB8SMN1; SMN2ALDH1A1TP53
SCHEMBL5473553 0.80 KDM4E (0.49) PKML3MBTL1SMN1; SMN2ALDH1A1TP53
SCHEMBL32670473 0.79 MEN1 (0.43) PKML3MBTL1SMN1; SMN2ALDH1A1TP53
SCHEMBL27778142 0.79 PKM (0.51) PKMNLRP3L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL23116582 0.78 NLRP3 (0.43) PKMNLRP3L3MBTL1ALDH1A1MAPT
SCHEMBL3135580 0.77 MAOB (0.56) PKMPSMB5L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL909534 0.75 NLRP3 (0.50) PKMNLRP3L3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348441-A1 BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR MEDSHINE DISCOVERY INC. (CN) 2023-11-02 US disclosed
US-20230348441-A1 BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR MEDSHINE DISCOVERY INC. (CN) 2023-11-02 US disclosed
WO-2021047674-A1 BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR 南京明德新药研发有限公司 2021-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348441-A1 BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR CRBN, CRKL, NCOR1 PKM 3422/4885PSMB5 499/4885PSMB8 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.